Skip to main content
. 2017 Jan 23;12(1):e0170234. doi: 10.1371/journal.pone.0170234

Table 3. Use of PNC by neonatal characteristics.

PNC P value crude Adj
n/N % OR 95% CI OR* 95% CI
GA
24–25 242/748 32.4 <0.0001 8.7 6.7–11.2 5.6 4.1–7.5
26–27 204/1276 16.0 <0.0001 3.4 2.7–4.4 2.5 1.9–3.3
28–29 99/1893 5.2 - - - -
Birthweight percentile
<10th 79/363 21.8 2.0 1.5–2.6 2.1 1.5–3.0
10-25th 110/614 17.9 1.6 1.3–2.0 1.4 1.1–1.9
>25th 356/2940 12.1 <0.0001 - - - -
Sex
Female 210/1778 11.8 0.001 - - - -
Male 335/2139 15.7 1.4 1.2–1.7 1.4 1.1–1.8
Multiple pregnancy
Singleton 392/2744 14.3 0.30 - - - -
Multiple 153/1173 13.0 0.9 0.7–1.1 0.9 0.7–1.2
PROM
No 413/2878 14.4 0.11 - - - -
Yes 121/981 12.3 0.8 0.7–1.0 0.9 0.7–1.1
Preeclampsia/eclampsia/HELLP
No 448/3313 13.5 0.16 - - - -
Yes 88/558 15.8 1.2 0.9–1.5 1.1 0.8–1.6
Caesarean
No 208/1341 15.5 0.03 - - - -
Yes 332/2551 13.0 0.8 0.7–1.0 1.1 0.9–1.4
Inborn
No 68/455 14.9 1.10 0.8–1.4 0.7 0.5–1.0
Yes 476/3456 13.8 0.5 - - -
Apgar score <7
No 343/2807 12.2 <0.0001 - - - -
Yes 150/837 17.9 1.6 1.3–1.9 0.9 0.7–1.2
Treatments
Antenatal steroids
No 62/419 14.8 0.62 - - - -
Yes 482/3465 13.9 0.9 0.70–1.2 1.1 0.8–1.5
Surfactant
No 36/927 3.9 <0.0001 - - - -
Yes 509/2983 17.1 5.1 3.6–7.2 1.3 0.8–1.9
Mechanical ventilation
No 10/877 1.1 <0.0001 - - - -
Yes 534/3030 17.6 18.5 9.9–34.8 7.7 3.8–15.8
NSAIDs to treat PDA
No 273/2789 9.8 <0.0001 - - - -
Yes 271/1110 24.4 3.0 2.5–3.6 1.8 1.5–2.3

* adjusted on gestational age

SGA, sex, PROM, preeclampsia/eclampsia/HELLP:, caesarean section, apgar score, surfactant, mechanical ventilation, NSAIDs to treat PDA

OR: odds ratio; 95% CI: 95% confidence interval. n: number receiving PNC N: total in group